Turning Point Therapeutics, Inc. - Common stock (TPTX): Price and Financial Metrics


Turning Point Therapeutics, Inc. - Common stock (TPTX): $76.01

0.52 (+0.69%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add TPTX to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

TPTX Stock Price Chart Interactive Chart >

Price chart for TPTX

TPTX Price/Volume Stats

Current price $76.01 52-week high $82.20
Prev. close $75.49 52-week low $23.77
Day low $75.98 Volume 2,843,300
Day high $76.01 Avg. volume 1,137,726
50-day MA $74.99 Dividend yield N/A
200-day MA $45.62 Market Cap 3.81B

Turning Point Therapeutics, Inc. - Common stock (TPTX) Company Bio


Turning Point Therapeutics, Inc. engages in the discovery and development of precision medicines for cancer and other diseases. It focuses on the design of novel chemical identities for established oncogene drivers with secondary resistant mutations, newly identified disease-driven targets, and potential targets regulating tumor microenvironment and tumor immunity. The company was founded by J. Jean Cui and Y. Peter Li in October 2013 and is headquartered in San Diego, CA.


TPTX Latest News Stream


Event/Time News Detail
Loading, please wait...

TPTX Latest Social Stream


Loading social stream, please wait...

View Full TPTX Social Stream

Latest TPTX News From Around the Web

Below are the latest news stories about Turning Point Therapeutics Inc that investors may wish to consider to help them evaluate TPTX as an investment opportunity.

Turning Point Therapeutics (TPTX) Investor Presentation - Slideshow

The following slide deck was published by Turning Point Therapeutics, Inc. in conjunction with this event....

SA Transcripts on Seeking Alpha | January 21, 2022

Read More 'TPTX' Stories Here

TPTX Price Returns

1-mo N/A
3-mo N/A
6-mo 1.90%
1-year 108.42%
3-year 38.88%
5-year N/A
YTD 59.35%
2021 -60.85%
2020 95.62%
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7698 seconds.